Skip to content
PS2023: The Virtual Trip
Session Videos
Sort...
By title from lowest to highest
By title from highest to lowest
By date from lowest to highest
By date from highest to lowest
Search
Session Tracks
Keynote
Society
Veterans
Policy
Science
Business
Doblin
Plant Medicine
Texas Eclipse 2024
Remove Filter
Grid View
List View
Keynote
Psychedelic Science 2023 Opening Ceremony
Maya Padilla
,
Governor Jared Polis
,
Gov. Rick Perry
Keynote
Reflections on Psychedelic Science 2023
Marwan and Noam
,
Snow Raven
Keynote
Addiction, family, plant medicine, and healing
Melissa Etheridge
Policy
The drug policy endgame: beyond public health
Jason Ortiz
,
Kassandra Frederique
,
Shaleen Title
Keynote
Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse
Robert Jesse
,
Michael Pollan
Keynote
Opening Dinner Honoring Roland R. Griffiths, Ph.D.
William Richards
,
Theresa Carbonaro
,
Katherine Bonson
Keynote
Psychedelics: Spirituality, Mindfulness, and Mortality – Personal reflections and visions for the future
Roland Griffiths
Business
Visionary Women: Transforming Psychedelic Medicine
Rachel Yehuda
Colorado
Regulating State Markets for Psychedelic-Assisted Services
Dominique D Mendiola
Keynote
Priorities for the next generation of psychedelic science
Joshua A Gordon
Business
The state of the psychedelic sector
Josh Hardman
Doblin
TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies
Jeannie Moller Fontana
Multidisciplinary
Amplifying the Wisdom of Psychedelic Elders
Mariavittoria Mangini
,
Patricia James
,
Ladybird Morgan
,
Kristina Soriano
Society
Sex and Psychedelics: Weaving Altered States for Healing and Pleasure
Monica Cadena
,
Leticia Brown
,
Britta Love
,
Laura Mae Northrup
Society
Proactive harm reduction by preparing set, setting, and substance
Phoenix aka Mohawk Greene
,
Mitchell Gomez
Society
Psychedelics, Conflict Resolution & Restorative Justice
Speakers
Plant Medicine
Queering Psychedelics
Alex Belser
,
Clancy Cavnar
Veterans
The Potential of Psychedelic Therapies for Veterans and their Families
Amber Capone
,
Marcus Capone
Veterans
PTSD. The Other War Most Combat Veterans Fight. Psychedelics and Finally Coming Home.
Bob Parsons
Policy
Visionary approaches: psychedelic policy in a global context
Kasia Malinowska
,
Steve Rolles
Policy
Designing a post-prohibition future
Paula Graciela Kahn
,
Betty Aldworth
,
Roman Haferd
,
Christopher Medina-Kirchner
,
Ariel Clark
Keynote
Maya Padilla
,
Governor Jared Polis
,
Gov. Rick Perry
Psychedelic Science 2023 Opening Ceremony
Welcome to Psychedelic Science 2023. Opening land acknowledgement. Opening address: Welcome to the movement. Opening address from Rick Doblin, Ph.D. Opening address from Governor Rick Perry. Opening address from Governor Jared Polis.
Keynote
Marwan and Noam
,
Snow Raven
Reflections on Psychedelic Science 2023
The critical examination of access, affordability, and reciprocity were key themes at Psychedelic Science 2023. Our community has been asked to consider the legacy of colonial and extractive systems, particularly as they impact the Global South and Indigenous ceremony and communities in our work. As a community, we must ensure that psychedelics do not become another space of exclusion for people of color and all those who have been denied equity in society.
Keynote
Melissa Etheridge
Addiction, family, plant medicine, and healing
In this session, Grammy-winning artist Melissa Etheridge shares her personal story of family addiction struggles, loss, healing, and transformation through plant medicines. Melissa addresses both the science and spiritual connections that led her to found the Etheridge Foundation, funding research into plant medicine treatments for opioid use disorder. From devastation and grief to a powerful determination to create access to more effective treatments for addiction, Melissa's cause is one of love and hope.
Policy
Jason Ortiz
,
Kassandra Frederique
,
Shaleen Title
The drug policy endgame: beyond public health
Prepare to be immersed in a thought-provoking discussion led by seasoned and visionary leaders, experts, and activists about challenging the status quo and redefining the parameters of drug policy. This opening session will explore the multifaceted dimensions that extend beyond public health like social and transformative justice, civil and human rights, and lasting systemic reform. We’ll discuss practical and principled approaches that prioritize harm reduction, community empowerment, and transformative justice. We seek a world where drug policy transcends its traditional boundaries, leading us towards a future of compassion, equity, and holistic well-being for all – join us!
Keynote
Robert Jesse
,
Michael Pollan
Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse
Michael Pollan is a renowned author and investigative journalist whose work explores the intersection of culture, nature, and consciousness. His 2018 book, “How to Change Your Mind,” catalyzed a new wave of interest in the field of psychedelic research. Always nuanced, insightful, and entertaining, Pollan has become the go-to figure for anyone seeking to understand the potential risks and benefits of these substances. Bob Jesse is a guiding force behind the contemporary re-emergence of psychedelics. In the mid-90s, he convened an expert group, the Council on Spiritual Practices, which was instrumental in forming the psilocybin research team at Johns Hopkins. Jesse co-authored that team's influential first study (2006) and has led the drafting of foundational documents: a Code of Ethics for Spiritual Guides (1995), an amicus brief for the U.S. Supreme Court (2005) in a successful religious liberty case, and a Statement on Open Science (2017) signed by numerous leaders in psychedelics. He has served on several boards in the field. Previously, Jesse trained at Hopkins in engineering, consulted for AT&T Bell Labs, and worked at Oracle Corp. as a VP of business development. At Bell Labs and at Oracle, his advocacy initiatives led to marked advances for lesbian and gay employees and their families. Currently, he continues to advise and collaborate with individuals and groups in the psychedelics space.
Keynote
William Richards
,
Theresa Carbonaro
,
Katherine Bonson
Opening Dinner Honoring Roland R. Griffiths, Ph.D.
Recorded June 21, 2023 at the Psychedelic Science Conference in Denver, Colorado. Attendees gathered to honor Roland R. Griffiths, PhD, Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, and founding Director of the Johns Hopkins Center on Psychedelic and Consciousness Research. The evening included a three-course meal featuring speeches from the colleagues and allies who have worked with Dr. Griffiths across his illustrious and illuminating career. In 1999, building on a long career of pharmacological research, Dr. Griffiths opened a new era in psychedelic science with a series of groundbreaking studies examining the usage of psilocybin for spiritual and therapeutic purposes, yielding its first landmark publication in 2006. Over the last 16 years, Dr. Griffiths and his team have published over 144 peer-reviewed articles about psychedelics in respected scientific journals. This research has led to a widespread reconsideration of the potential of psychedelics in the fields of science and medicine, and inspired a new generation of researchers to follow in his footsteps. In 2020, Dr. Griffiths founded the Johns Hopkins Center for Psychedelic and Consciousness Research with $17m in philanthropic funding, establishing the first permanent center for psychedelic research in North America. In 2022, Dr. Griffiths announced that he had been diagnosed with Stage IV cancer. He has recently begun to share his thoughts on mortality and his hope for the continued inquiry into the potential of psychedelics for spiritual growth, while continuing to write forthcoming scientific publications.
Keynote
Roland Griffiths
Psychedelics: Spirituality, Mindfulness, and Mortality – Personal reflections and visions for the future
Recorded June 22, 2023 at the Psychedelic Science Conference in Denver, Colorado. Roland Griffiths, Ph.D., is Professor in the Departments of Psychiatry and Neurosciences and Founding Director of the Center for Psychedelic and Consciousness Research at the Johns Hopkins University School of Medicine. His principal research focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs and he is author of over 400 scientific publications and has trained more than 50 postdoctoral research fellows. About 20 years ago, he initiated a research program investigating effects of the classic psychedelic substance psilocybin. Completed and ongoing studies include those in healthy volunteers, in beginning and long-term meditators, and in religious leaders. Therapeutic studies with psilocybin include treatment of psychological distress in cancer patients, major depressive disorder, nicotine addiction, anorexia nervosa, and several other psychiatric disorders. Related studies of brain imaging and drug interactions are examining pharmacological and neural mechanisms of action. His research group has also conducted a series of survey studies characterizing and comparing various naturally-occurring and psychedelic experiences resulting in enduring changes in beliefs, attitudes, moods, and behavior.
Business
Rachel Yehuda
Visionary Women: Transforming Psychedelic Medicine
Vicky Dulai, founder of Compassion For Addiction, a non-profit dedicated to a trauma informed and psychedelic medicine approach to treating addiction, and board member of MAPS, will moderate a discussion with Amy Emerson, CEO of MAPS Public Benefit Corporation, and Rachel Yehuda, Ph.D., an endowed professor of Psychiatry and Neuroscience of Trauma at Icahn School of Medicine at Mount Sinai. The women will talk about lessons they have learned along the way and how they are leading the way in the psychedelic space.
Colorado
Dominique D Mendiola
Regulating State Markets for Psychedelic-Assisted Services
Everyone has a different view on these new state frameworks for psychedelic healing - hear from those tasked with regulating this new industry and helping to ensure these programs are successful, equitable, and safe.
Keynote
Joshua A Gordon
Priorities for the next generation of psychedelic science
Over the last decade, interest in the study of psychedelic drugs has grown tremendously, yielding a new generation of research centers, clinical trials, and neuroscience studies. In response to this growing wave of inquiry, in November of 2022, the National Institute of Mental Health (NIMH) issued a notice outlining its priorities and criteria for new grant applications related to the study of psychedelic drugs, emphasizing a need for deeper research into underlying mechanisms, as well as more robust study designs in clinical and translational research. In this session, NIMH Director Joshua A. Gordon, M.D., Ph.D. and trauma researcher and NIMH grant recipient Barbara O. Rothbaum, Ph.D. of Emory University discuss the strengths and weaknesses of latest wave of psychedelic research, and what we hope to learn from the next generation of rigorous investigations into the neurobiology and therapeautic applications of psychedelic drugs.
Business
Josh Hardman
The state of the psychedelic sector
This talk aims to provide a rapid introduction to the state of the nascent psychedelic sector, fertilising the ground for more substantive discussions on this track. Helped along by data visualisations, Hardman surveys the financial, research and policy contexts in which psychedelic businesses are embedded; and, increasingly, are shaping. The talk finishes by reviewing a number of open questions surrounding the future of the psychedelic sector, from its unfolding clinical evidence base to its commercial viability.
Doblin
Jeannie Moller Fontana
TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies
TREAT California, a citizen-led ballot initiative, will revolutionize mental healthcare in California by safely and ethically harnessing the power of psychedelic medicines. Following the roadmap of the highly successful stem cell agency (also formed by ballot initiative), it will establish the largest psychedelic funding agency in the world. The TREAT Institute will be funded with $5 Billion for research and affordable access to these powerful medicines. Come learn about this initiative, how we will deliver on the potential for psychedelic medicines to heal without ‘medicalizing’ them, how we will provide these therapies to all Californians in need (regardless of ability to pay), how this funding agency will be different from a typical government agency, and why decriminalization is not enough. We have a remarkable and realistic opportunity to achieve the single most significant expansion of treatments and therapies applicable to mental health and addiction in generations.
Multidisciplinary
Mariavittoria Mangini
,
Patricia James
,
Ladybird Morgan
,
Kristina Soriano
Amplifying the Wisdom of Psychedelic Elders
Founded as an organization open to all genders, the Women's Visionary Council (WVC) is placing a special focus on elders and the transfer of knowledge between generations. While psychedelic communities in the Western world are composed largely of younger people, elders bring balance, clarity and insights drawn from years of experience. They consider the long-term impact of decisions about psychedelic compounds on vulnerable groups and support pragmatic approaches to the resolution of conflict. As the rapid growth of psychedelic companies and organizations enter a new phase, informed advice and reflection from elders is increasingly needed to light the path forward. The WVC will host a panel discussion with five elders, including three from its board of directors. The conversation will also highlight the work of other elders in psychedelic communities who have made significant contributions as spiritual leaders, trusted healers, mature artists, and seasoned activists.
Society
Monica Cadena
,
Leticia Brown
,
Britta Love
,
Laura Mae Northrup
Sex and Psychedelics: Weaving Altered States for Healing and Pleasure
Where does sex fit into our cultural conversations on psychedelics? How does one go about weaving the erotic with the psychedelic? Join somatic sex educator Britta Love, somatic psychotherapist Laura Mae Northrup, and sex therapist Leticia Brown for a conversation about consent, altered states of consciousness, and how psychedelics can shift our relationship to our erotic selves, moving us towards deeper pleasure and more embodied play.
Society
Phoenix aka Mohawk Greene
,
Mitchell Gomez
Proactive harm reduction by preparing set, setting, and substance
Join two harm reduction superheroes reflecting on the theory and practice of risk mitigation and benefit maximization. This fast-paced, forward-thinking and practical address will consider the power of mindset (set), physical and environmental conditions (setting), and the very drugs themselves (substance). Attendees will be offered novel and nuanced perspectives focused on empowering individuals to better understand the context of their drug use, ensuring safer and more intentional experiences through personal awareness and systemic change.
Society
Speakers
Psychedelics, Conflict Resolution & Restorative Justice
This panel brings together experts from the fields of peace-building, conflict resolution, and restorative justice to explore the potential applications of psychedelics in promoting conflict resolution, facilitating restorative justice processes, and building peace. Panelists will share research, experiences, and address ethical considerations associated with integrating psychedelics into these transformative processes. Ultimately, the panel aims to contribute to the ongoing discourse on healing, reconciliation, and building peaceful societies through the integration of psychedelics within conflict resolution and restorative justice frameworks.
Plant Medicine
Alex Belser
,
Clancy Cavnar
Queering Psychedelics
This panel will explore some LGBT+ or “queer” perspectives on the therapeutic, spiritual, and social use of psychedelics. The panelists will incorporate their clinical and personal experiences to emphasize the role of community as a vital agent of healing among queer people and make recommendations for queer-inclusive psychedelic therapy and research. They will also draw from queer history, including the use of psychedelics during the AIDS crisis and for “conversion therapy.”
Veterans
Amber Capone
,
Marcus Capone
The Potential of Psychedelic Therapies for Veterans and their Families
In this session, we will hear the seemingly unlikely story of how psychedelic therapy arrived within the VA, and updates on psychedelic research programs underway
Veterans
Bob Parsons
PTSD. The Other War Most Combat Veterans Fight. Psychedelics and Finally Coming Home.
As a United States Marine Corps Vietnam War Combat Veteran and a self-made serial entrepreneur, Bob Parsons is using his platform to address PTSD and highlight the importance of new pathways to healing, specifically psychedelic assisted therapies. While Parsons still suffers from PTSD from his tour in Vietnam, he credits psychedelics with helping him “come home” 49-years after the war. Now he’s on a mission to help other veterans. This is his unfiltered story.
Policy
Kasia Malinowska
,
Steve Rolles
Visionary approaches: psychedelic policy in a global context
While international drug policy has historically tended to mirror that of the United States’ prohibitionist approach, times are changing - and we are ready to change, too. This conversation will situate psychedelic policy changes in context of broader drug policy reform, propose regulatory solutions, and offer a path forward for a unified approach toward a post-prohibition world. Don’t miss this superstar lineup of long-time leaders in global reform!
